A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1 - Wikidata - wikimedia - TriplyDB

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1

http://www.wikidata.org/entity/Q33921027

about

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems IL1R9 Is Evolutionarily Related to IL18BP and May Function as an IL-18 Receptor.Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions.The interleukin-1 family: back to the future The neuron-specific interleukin-1 receptor accessory protein is required for homeostatic sleep and sleep responses to influenza viral challenge in mice Neuroimmune modulation following traumatic stress in rats: evidence for an immunoregulatory cascade mediated by c-Src, miRNA222 and PAK1.Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory protein.Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.Brain-specific interleukin-1 receptor accessory protein in sleep regulation.Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus.Splicing-Dependent Trans-synaptic SALM3-LAR-RPTP Interactions Regulate Excitatory Synapse Development and Locomotion.Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults.Heat shock proteins and chronic fatigue in primary Sjögren's syndrome.Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue Interleukin (IL)-1 in rat parturition: IL-1 receptors 1 and 2 and accessory proteins abundance in pregnant rat uterus at term - regulation by progesterone.AIM 2 inflammasomes regulate neuronal morphology and influence anxiety and memory in mice Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization Suppression of innate inflammation and immunity by interleukin-37.Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target.Cytokines and cytokine networks target neurons to modulate long-term potentiation.Sleep and immunomodulatory responses to systemic lipopolysaccharide in mice selectively expressing interleukin-1 receptor 1 on neurons or astrocytes.Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection.Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology.Physiologically normal 5% O2 supports neuronal differentiation and resistance to inflammatory injury in neural stem cell cultures.Increased levels of cytokines in cerebrospinal fluid of children with aseptic meningitis caused by mumps virus and echovirus 30.Contribution of interleukin-1 receptor accessory protein B to interleukin-1 actions in neuronal cells.The family of the interleukin-1 receptors.Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia-reperfusion injury.TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse.Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism

P2860

Q24606766-DDC1D9A3-4E19-4852-A6C4-415537748224 Q26786915-13A25F5F-A115-45B6-8947-7D307E3FC22D Q30395586-198E2956-19FA-465B-8BFD-B74EEB990C07 Q34054560-23B870B7-2C2D-4D93-9D74-F3BE93FF715C Q34391415-F6FFC524-9B4F-4AD8-82F0-596AEAD9501C Q35567247-1DB4629F-84D6-4A54-9D06-1349EC68BB23 Q35666739-8FDC34AD-DD14-43EB-AB0C-223A87C7AED8 Q35680208-D27E9D18-2C33-4C7C-B38C-208A626ACA87 Q35750038-94EDB7A4-C415-4BC8-ADA7-5CB97067862F Q35850578-0E4CD08A-82E9-474A-BF37-93AC94FCFA3E Q36056747-315FFB33-D5F6-4A88-A76C-5482BC17325C Q36082701-14A21A77-A2F4-4409-BB94-3C4ACDD3A5A8 Q36132847-B16FBEE8-32DF-4AC9-8144-1CDDDC45FA4C Q36351585-1D157985-975E-40F0-9A4B-353D9D654E48 Q36612395-6DDF878E-CAB1-472D-B44E-39EF69F3FAE7 Q36719483-BC7461C0-9FB8-4C99-BF2F-3523D651F259 Q36994635-7DBD5F97-D551-4CC5-B3BB-036BEF4E663F Q36994826-BB9955E3-CF8F-452C-BA5D-B4709E34E796 Q37128549-B3D39E52-3166-4B3E-B4A2-3F116FBEC7D1 Q37209334-79004BC9-F97A-4D64-867C-7503DED53B94 Q37213119-CE3AFCA6-3A12-4534-8E6D-EF5CFE670E75 Q37213297-3EE54E3A-5F6B-436C-B388-91535451AACE Q37959134-DF6D2FA5-65FD-43A9-B6B0-9634B033F530 Q39220104-80D8897E-726F-4375-B3FD-A8BDA1B1633A Q40099652-59883ACA-6B99-4A60-9C3F-84AB7D80E71C Q40213306-E3F90C2D-CE3E-4B25-A30A-3BF8417A076F Q41614701-A1BE1E5E-AA71-43C5-ABFA-205BAF2D1AD2 Q42020000-656EC39C-0B5E-4C2D-AC13-6B26BFA03262 Q42237802-F6A38006-7DF0-4291-A96E-3CE20FC3920E Q44310929-B4B19B30-664D-4D57-A15B-C034A40AE805 Q47285858-F8670054-7329-4F99-9DCF-B5533CFD321A Q47721585-15D40DE9-EE1F-46E4-BF57-ECA493E06792 Q52331413-E372FA9A-46DC-43FD-A52D-D1F2CAB68DDC Q58794859-F5241910-19D3-4647-B020-2D150075C392

P2860

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1

http://www.wikidata.org/entity/Q33921027

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A central nervous system-restr ...... nal responses to interleukin-1

@ast

A central nervous system-restr ...... nal responses to interleukin-1

@en

type

label

A central nervous system-restr ...... nal responses to interleukin-1

@ast

A central nervous system-restr ...... nal responses to interleukin-1

@en

prefLabel

A central nervous system-restr ...... nal responses to interleukin-1

@ast

A central nervous system-restr ...... nal responses to interleukin-1

@en

P1433

Q33921027-091A3B26-2D1F-4734-8F71-17E7F45EE5E6

P1476

Q33921027-E4C5BB4E-A826-4630-97B5-0CB6A61E9A47

P2093

Q33921027-04F6916F-2850-41B5-BB55-46C3B3549984

Q33921027-203F7425-4F9F-4A05-AA0D-D63CDEEE3AA4

Q33921027-518C6C7D-41F2-4C22-8397-0753F96CC7E1

Q33921027-74276D19-0A2D-4BB5-BDCD-CBBEAF02A882

Q33921027-775178A1-3994-47CA-8851-7CDCE9E76952

Q33921027-872345BB-94E7-431F-8C41-A7CAB53B6C4F

Q33921027-93C89923-63C6-4585-8C89-08F761D48CB8

Q33921027-B8DDB556-125F-4890-A75A-C86EB620F40F

Q33921027-BF047305-518A-40AA-9E1C-0454466E3A64

Q33921027-D95C54FE-69A2-4909-9FC5-FB696B53762C

P2860

Q33921027-01AFAF42-DBB5-4B64-A3DB-A130772349E0

Q33921027-02C75129-1977-442D-9CE1-29C702FF5F66

Q33921027-0B886F47-59D0-44D3-AA05-67DB0B1E039D

Q33921027-0E4A86CD-48A3-4BBC-B188-BE1D22D1C230

Q33921027-0F4B6CD1-9BFE-41BE-9806-8AB640AB15A1

Q33921027-191CEC72-72EB-419D-B585-4C86208AA7DA

Q33921027-19796FA5-1021-455B-86E0-B8F4342B90C4

Q33921027-21A0CF93-0D5E-4E99-BC03-30CB8E28D25F

Q33921027-232B6A39-F9DD-4778-A737-8A9377C2AB98

Q33921027-27A92A9E-3E12-48EB-9E4F-3407DA4B217B

P304

Q33921027-8F1BE043-184C-4D9C-BFD4-E4BBF03B96F6

P31

Q33921027-2F53E754-38F1-4074-83B6-560D8481756D

P356

Q33921027-4401FD96-7EBA-4CD6-9307-29D6306485DB

P407

Q33921027-54FABA02-E9DF-4848-8090-A16CDCB86CAA

P433

Q33921027-48FA0B60-9650-4FF9-BBD0-DAA07C588D31

P478

Q33921027-753647B8-599B-4D55-BA99-20B353C8F461

P577

Q33921027-BC526A3F-C6AD-42E2-9584-E0933212B493

P5875

Q33921027-F41DBEC9-8759-4B88-85EC-4080C19E9AF1

P698

Q33921027-8DE1F711-DF31-4E82-B666-866C4AFE17BB

P921

Q33921027-6a17b99d-8f11-4108-8972-3e27cdc247a6

P932

Q33921027-FCE74A42-6FB0-4464-8125-0048EDDF22C9

P356

J.IMMUNI.2009.03.020

P1433

P1476

A central nervous system-restr ...... nal responses to interleukin-1

@en

P2093

Brian P Lipsky

http://www.w3.org/2001/XMLSchema#string

Chris Russell

http://www.w3.org/2001/XMLSchema#string

Dirk E Smith

http://www.w3.org/2001/XMLSchema#string

Jacqueline Kirchner

http://www.w3.org/2001/XMLSchema#string

John E Sims

http://www.w3.org/2001/XMLSchema#string

Kelly Hensley

http://www.w3.org/2001/XMLSchema#string

Marie-Michèle Plante

http://www.w3.org/2001/XMLSchema#string

Randal R Ketchem

http://www.w3.org/2001/XMLSchema#string

Serge Rivest

http://www.w3.org/2001/XMLSchema#string

Vincent Boissonneault

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily

Structural basis for signal transduction by the Toll/interleukin-1 receptor domains

SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2)

The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)

Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex

MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.

Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

P304

817-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2009.03.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26252420

http://www.w3.org/2001/XMLSchema#string

P698

19481478

http://www.w3.org/2001/XMLSchema#string

P921

P932

4103746

http://www.w3.org/2001/XMLSchema#string